Endocrinology. Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety

By Ferraretti A.P.   Gianaroli L.   Magli C.   Fortini D.   Selman H.A.  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1457-1460

Oxford University Press

Access to resources Recommend Favorite

Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis

By Chen Ying   Zhang Yi   Hu Min   Liu Xiru   Qi Hongbo  

Gynecological Endocrinology, Vol. 30, Iss. 6, 2014-06 ,pp. : 431-437

Informa Healthcare

Access to resources Recommend Favorite

Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study

By Griesinger G.   von Otte S.   Schroer A.   Ludwig A.K.   Diedrich K.   Al-Hasani S.   Schultze-Mosgau A.  

Human Reproduction, Vol. 22, Iss. 5, 2007-05 ,pp. : 1348-1352

Oxford University Press

Access to resources Recommend Favorite

Infertility. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication

By Itskovitz-Eldor J.   Kol S.  

Human Reproduction, Vol. 15, Iss. 9, 2000-09 ,pp. : 1965-1968

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Humaidan P.  

Human Reproduction, Vol. 20, Iss. 5, 2005-05 ,pp. : 1213-1220

Oxford University Press

Access to resources Recommend Favorite